Efficacy and tolerance of a low dose compared with a standard regimen of Didanosine (ddl): a prospective randomized comparative study

Christoph Stephan(Goethe University Frankfurt), Nathan Clumeck(Centre Hospitalier Universitaire de Saint-Pierre), Cécile Thioux, Sara Marinelli(Institute of Cell Biology and Neurobiology), Jean‐Paul Van Vooren(Université Libre de Bruxelles)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
January 1, 1993
Cited by 0

Related Papers

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003
|Cancer|2004|143